NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Drug Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Atherosclerosis Therapy



New atherosclerosis therapy research from China Pharmaceutical University outlined



March 2nd, 2007

Current study results from the report, "Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails," have been published. "Antioxidants have been expected to have potential as antiatherogenic agents. Crocetin is a natural carotenoid antioxidant isolated from Gardenia jasminoids Ellis," scientists in Nanjing, People's Republic of China report.

"Therefore, in the present study, we investigated the inhibitory effect of Crocetin on experimental atherosclerosis in quails. The atherosclerosis model was established by feeding hyperlipidamic diet to quail and Crocetin (25, 50, 100 mg/kg/day) was administered by oral gavage. At the 9th week, serum...


Source: Drug Week (2007-03-02)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login